Furthermore, an elevated level of MAGI2-AS3 is associated with better relapse-free survival for patients with triple-negative breast cancer subtype (absence of estrogen and progesterone receptors, no amplification of human epidermal growth factor receptor HER2) associated with a poor prognosis [232]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.